These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12102260)

  • 1. Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody.
    Salama AD; Delikouras A; Pusey CD; Cook HT; Bhangal G; Lechler RI; Dorling A
    Am J Transplant; 2001 Sep; 1(3):260-9. PubMed ID: 12102260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
    Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
    Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway.
    Narayanan K; Jaramillo A; Phelan DL; Mohanakumar T
    Eur J Immunol; 2004 Aug; 34(8):2303-12. PubMed ID: 15259028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
    Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
    Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
    Jordan SC; Lorant T; Choi J; Kjellman C; Winstedt L; Bengtsson M; Zhang X; Eich T; Toyoda M; Eriksson BM; Ge S; Peng A; Järnum S; Wood KJ; Lundgren T; Wennberg L; Bäckman L; Larsson E; Villicana R; Kahwaji J; Louie S; Kang A; Haas M; Nast C; Vo A; Tufveson G
    N Engl J Med; 2017 Aug; 377(5):442-453. PubMed ID: 28767349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury.
    Park WD; Grande JP; Ninova D; Nath KA; Platt JL; Gloor JM; Stegall MD
    Am J Transplant; 2003 Aug; 3(8):952-60. PubMed ID: 12859529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients.
    Sharma M; Webber SA; Zeevi A; Mohanakumar T
    Hum Immunol; 2019 Apr; 80(4):248-256. PubMed ID: 30710563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients.
    Kupin WL; Venkat KK; Hayashi H; Mozes MF; Oh HK; Watt R
    Transplantation; 1991 Feb; 51(2):324-9. PubMed ID: 1994523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of renal allografts hinges on responses of the microvascular endothelium.
    Mannam VK; Lewis RE; Cruse JM
    Exp Mol Pathol; 2013 Apr; 94(2):398-411. PubMed ID: 22710034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model.
    Fukami N; Ramachandran S; Narayanan K; Liu W; Nath DS; Jendrisak M; Chapman W; Mohanakumar T
    Transplantation; 2012 Feb; 93(4):364-72. PubMed ID: 22273841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Active Antibody-Mediated Rejection with Linear IgG Deposition on Glomerular Capillaries in a Kidney Transplant Recipient.
    Miura K; Shirai Y; Kaneko N; Yabuuchi T; Ishizuka K; Horita S; Furusawa M; Unagami K; Okumi M; Ishida H; Tanabe K; Koike J; Honda K; Yamaguchi Y; Hattori M
    Nephron; 2020; 144 Suppl 1():97-101. PubMed ID: 33238286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells.
    Sumitran-Karuppan S; Tyden G; Reinholt F; Berg U; Moller E
    Transpl Immunol; 1997 Dec; 5(4):321-7. PubMed ID: 9504155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.
    Heinemann FM; Roth I; Rebmann V; Arnold ML; Witzke O; Wilde B; Spriewald BM; Grosse-Wilde H
    Hum Immunol; 2007 Jun; 68(6):500-6. PubMed ID: 17509449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro removal of anti-HLA IgG antibodies from highly sensitized transplant recipients by immunoadsorption with protein A and protein G sepharose columns: a comparison.
    Barocci S; Nocera A
    Transpl Int; 1993 Jan; 6(1):29-33. PubMed ID: 8452629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection.
    Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV
    J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.